NCT06660082

Brief Summary

The vestibulo-ocular reflex (VOR) induces a compensatory movement in the eye when the head is rotated, to maintain stable vision when we move. It originates in the peripheral vestibular system, which detects head movements. It is particularly effective for rapid head movements, as tested in the Head Impulse Test (HIT). In acute unilateral vestibular deficit (AUVD), the VOR deficit is compensated for by a substitution saccade, more commonly known as catch up saccade, that contribute to refocus the gaze and maintain vision during head rotations. Recent technological advances have made it possible to make high-quality recordings during HIT (video Head Impulse Test, vHIT), leading to the identification of substitution saccades of variable latency. Our team has shown that saccades of shorter latency lead to better visual function (Hermann et al., 2017) and that the cerebellum is involved in the development of these saccades (Hermann et al., 2023), suggesting a learning effect rather than the de novo appearance of particular saccades. The main hypothesis of this study is that the mechanisms underlying short-latency substitution saccades, which seems to guarantee good functional recovery, depend on learning occurring from the first days after an acute unilateral vestibular deficit. We also hypothesise that early physiotherapeutic rehabilitation of the VOR under Head Impulse Test conditions would promote this learning process and the development of early catch-up saccades. One of the causes of AVD is the resection of cochleovestibular schwannomas. This procedure involves a neurotomy, i.e. complete vestibular deafferentation, which is precisely known due to the scheduled nature of the surgery. The exact moment of onset of vestibular damage is therefore known, unlike other vestibular pathologies. Hospitalisation is necessary in the immediate aftermath of surgery, with the presence of physiotherapists on the wards. In addition, there is no spontaneous recovery of the vestibular deficit. These patients therefore represent the ideal acute unilateral vestibular deficit model for testing our hypothesis. Two studies using vHIT in the aftermath of vestibular schwannoma resection surgery (Pogson et al. 2022; Mantokoudis et al. 2014) also allow us to confirm the safety and feasibility of our protocol in this patient population.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
12mo left

Started May 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress50%
May 2025May 2027

First Submitted

Initial submission to the registry

October 24, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 26, 2024

Completed
7 months until next milestone

Study Start

First participant enrolled

May 13, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2027

Last Updated

May 16, 2025

Status Verified

May 1, 2025

Enrollment Period

2 years

First QC Date

October 24, 2024

Last Update Submit

May 14, 2025

Conditions

Keywords

Vestibular rehabilitationVestibular schwannomaVestibulo-ocular Reflex (VOR)video Head Impulse Test (vHIT)

Outcome Measures

Primary Outcomes (1)

  • First Substitution Saccade Latency after treatment

    Mean latencies (in milliseconds) of the first substitution saccade assessed by vHIT examination, in both groups. Eye movements are recorded during the vHIT examination, carried out by one of the expert practitioners (physiotherapist or doctor) investigating the study. Data from the vHIT are extracted, enabling offline analysis of oculomotor parameters, including the latency of the first substitution saccade in milliseconds. These analyses are carried out off-line by the principal investigator, who was trained and experienced in this type of analysis, using software that allowed standardised and automated analysis, blinded to the group.

    Day 7

Secondary Outcomes (6)

  • First Substitution Saccade Latency during the First Week

    Everyday from post-surgery Day 1 to Day 6

  • First Saccade Latency after treatment (follow-up)

    At post-surgery Day 45 and 3rd month

  • First saccades amplitude after treatment

    Post surgery Day 7, Day 45 and 3rd month

  • First saccades amplitude during first week

    Everyday from post-surgery Day 1 to Day 6

  • Balance and gait assessment

    At Day -1 (pre-surgery), and post-surgery Day 7, Day 45 and 3rd Month

  • +1 more secondary outcomes

Study Arms (2)

Experimental Group

EXPERIMENTAL

Participants included in this group will undergo experimental treatment as described below. Head movements

Procedure: Experimental treatment: Head movements

Control Group

SHAM COMPARATOR

Participants included in this group will undergo sham-treatment as described below. Eye movements without head movements

Procedure: Sham treatment: only eye movements

Interventions

These are gaze stabilisation exercises under vHIT control, between post-operative days 1 to 6. The patient sits facing a wall 2 metres away. The investigator places the vHIT device on the participant's head and ensures that it fits properly. This is followed by an initial calibration phase (the patient must follow a laser dot with his eyes). Then comes stimulation phase: the investigator, standing behind the patient, places his hands on the sides of the patient's lower jaw, which he is asked to clench. The investigator asks the subject to stare at a visual target on the wall in front of the patient. The investigator then performs a series of low-amplitude, high-speed head movements in the plane of the lateral canals and on the side of the vestibular deficit. The patient is encouraged to resume fixation of the visual target as quickly as possible. For each treatment session, patients should perform a minimum of 10 impulses and a maximum of 30 impulses on the deafferented side. Each

Also known as: Head movements
Experimental Group

These are visually guided saccade exercises under vHIT device control but without head movements (saccade module), between post-operative days 1 to 6. For this sham treatment, the modalities are identical to the experimental treatment session, up to the calibration phase described above. For the stimulation phase, the investigator, standing behind the patient, places his hands on the sides of the patient's lower jaw, which he is asked to clench. The investigator asks the subject to stare at a visual target on the wall in front of the patient. The target then jumps horizontally to trigger visually guided saccades or slides horizontally to trigger an eye-tracking movement. The investigator stabilises the patient's head to prevent any head movement. The patient is encouraged to resume or maintain fixation of the visual target as quickly as possible. A minimum of 5 horizontal saccade sequences and 5 horizontal eye-tracking sequences will be performed. Each training session lasts approxi

Control Group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients with unilateral vestibular schwannoma and programmed surgery
  • vestibulo-ocular reflex gain :
  • on pathological side \> 0.50
  • on healthy side \> 0.80
  • all information's concerning the study given more than 15 days before surgery and consent collected the day before surgery

You may not qualify if:

  • Radiotherapy treatment prior to surgery.
  • Resumption of surgery
  • Presence of bilateral vestibular schwannomas
  • Normal or Corrected to normal distance visual acuity \< 5/10
  • Presence of other aetiologies that may explain the ataxic syndrome and/or oscillopsias
  • Oculomotor paralysis, ocular instability in primary position
  • Use of medications that compromise eye movement (psychotropic drugs)
  • Cervical spinal pathology with instability (contraindication for vHIT)
  • Cochlear implantation
  • Non-stabilized medical condition
  • Patient under guardianship
  • Patient not affiliated to a social security scheme
  • Patient participating any other interventional study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pierre Wertheimer Hospital - Neurological Hospital

Bron, 69677, France

RECRUITING

MeSH Terms

Conditions

Neuroma, Acoustic

Interventions

Head Movements

Condition Hierarchy (Ancestors)

NeurilemmomaNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeuromaNerve Sheath NeoplasmsNeoplasms, Nerve TissueCranial Nerve NeoplasmsNervous System NeoplasmsNeoplasms by SitePeripheral Nervous System NeoplasmsVestibulocochlear Nerve DiseasesRetrocochlear DiseasesEar DiseasesOtorhinolaryngologic DiseasesOtorhinolaryngologic NeoplasmsCranial Nerve DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

MovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

HERMANN RH Ruben, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
Participants will not be aware of the experimental or sham status of the arm they'll be allocated to. Investigator realising offline analysis will not know the arm of allocation of the subject they are analysing.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Exploratory, single-centre, randomised, sham-controlled, single-blind, superiority study, with comparison of two groups.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 24, 2024

First Posted

October 26, 2024

Study Start

May 13, 2025

Primary Completion (Estimated)

May 1, 2027

Study Completion (Estimated)

May 1, 2027

Last Updated

May 16, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations